JPH05124935A - Hair growth promoter - Google Patents

Hair growth promoter

Info

Publication number
JPH05124935A
JPH05124935A JP28533791A JP28533791A JPH05124935A JP H05124935 A JPH05124935 A JP H05124935A JP 28533791 A JP28533791 A JP 28533791A JP 28533791 A JP28533791 A JP 28533791A JP H05124935 A JPH05124935 A JP H05124935A
Authority
JP
Japan
Prior art keywords
hair
pdgf
hair growth
growth
platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP28533791A
Other languages
Japanese (ja)
Inventor
Kenta Mori
建太 森
Shinichi Meguro
真一 目黒
Hidefumi Kidena
英史 貴傳名
Noriko Hirayama
紀子 平山
Mitsuyuki Hotta
光行 堀田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP28533791A priority Critical patent/JPH05124935A/en
Publication of JPH05124935A publication Critical patent/JPH05124935A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide a hair growth promoter capable of stimulating hair mother cell proliferation leading to contribution to hair growth in terms of hair cycle. CONSTITUTION:The objective promoter giving hair growing activity along with depilation-inhibitory activity through hair mother cell activation, hair growth promotion and depilation-preventive effect, contains, as an active ingredient, platelet-derived growth factor (including PDGF, its effective fragment, its modified product, a modified product from effective fragments of PDGF, or mixture thereof). The PDGF can be isolated from the plasma containing platelet in the blood of animals such as human being, mice or swine (e.g. human platelet) by ion exchange column chromatography, affinity column chromatography, gel filtration and/or dialysis, etc. It is preferable that the amount of the PDGF to be formulated in a cosmetic or hair tonic be 1ng to 1mug/ml (or g) [esp. 10ng to 1mug/ml (or g)].

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は毛成長促進剤に関するも
のであり、詳しくは、毛母細胞の賦活化、毛の成長促
進、抜毛防止効果等により育毛、養毛及び脱毛防止作用
を与える毛成長促進剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair growth-promoting agent, and more specifically, it provides hair growth, hair nourishment and hair loss prevention effects by activating hair mother cells, promoting hair growth, and preventing hair loss. It relates to growth promoters.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】毛周期
のメカニズムはおよそ次の通りである。毛が成長する期
間、毛包は成長期にあると呼ばれ、その後毛の成長が停
止し、成長期より萎縮した状態の毛包を有するとき、毛
包は休止期にあると呼ばれる。成長期の毛包が休止期へ
移行するとき退行期を経る。即ち毛周期は、成長期、退
行期、休止期を繰り返す。
2. Description of the Related Art The mechanism of the hair cycle is roughly as follows. A hair follicle is said to be in the anagen phase during the growth of hair, and when the hair follicles subsequently stop growing and have hair follicles in a contracted state from the anagen phase, the hair follicle is said to be in the telogen phase. When the growing hair follicles enter the resting phase, they undergo a catagen. That is, the hair cycle repeats a growth period, a regression period, and a rest period.

【0003】例えば、男性型脱毛症は、その本態が毛包
の数の減少ではなく、硬毛がその大きさを減じて行くこ
とである。その機構は、毛周期を繰り返すうち、次第に
サイズを減じていく毛包の血管網は萎縮し、神経叢は毛
包から解離するが、エネルギー代謝にかかわる酵素活性
には、硬毛との間に質的相違がないことが知られてい
る。つまり、男性型脱毛症の成立途上で軟毛が増加する
のは、毛周期が短縮し、高い休止期率の状態で毛包の世
代交代が行われるためである。これは、臨床的にも禿げ
る前に抜け毛の目だつ現象と一致することが確認されて
いる。
[0003] For example, androgenetic alopecia is not the decrease in the number of hair follicles but the decrease in the size of terminal hairs. The mechanism is that the vascular network of the hair follicle, which gradually decreases in size during repeated hair cycles, atrophies and the plexus dissociates from the hair follicle, but the enzymatic activity involved in energy metabolism causes It is known that there is no qualitative difference. That is, the reason why vellus increases during the development of androgenetic alopecia is that the hair cycle is shortened and the generation of hair follicles is changed at a high resting period. It has been confirmed clinically that this is consistent with the phenomenon of prominence of hair loss before baldness.

【0004】従来の育毛、養毛及び脱毛防止剤は、天然
物から抽出したエキス類、ビタミン類、アミノ酸類、ホ
ルモン類等が使われてきた。例えば、毛乳頭の毛細血管
拡張とその持続時間の延長、動物実験による毛の成長促
進を指標に、トウガラシチンキ、ビタミンE、塩化カプ
ロニウム、センブリそのほかの植物抽出物などが種々の
割合で配合された育毛剤が、あるものはマッサージとの
併用で多数市販されている。
Extracts, vitamins, amino acids, hormones and the like extracted from natural products have been used as conventional hair growth, hair nourishing and hair loss preventing agents. For example, capsicum tincture, vitamin E, capronium chloride, senburi and other plant extracts were mixed in various ratios, with the indicators of capillary expansion of the papilla and its duration, and hair growth promotion in animal experiments. Many hair restorers are commercially available in combination with massage.

【0005】しかしながら、従来の技術では毛成長促進
に関しては顕著な効果が無く、より効果のあるものが期
待されていた。従って、本発明の目的は、毛母細胞の成
長増殖を促して毛周期上、育毛に寄与することができる
毛成長促進剤を提供することにある。
However, the conventional techniques have no remarkable effect on promoting hair growth and are expected to be more effective. Therefore, an object of the present invention is to provide a hair growth promoter that promotes growth and proliferation of hair mother cells and contributes to hair growth in the hair cycle.

【0006】[0006]

【課題を解決するための手段】上記課題を解決すべく本
発明者は、鋭意検討した結果、血液血小板中に多く含ま
れる血小板由来成長因子(PDGF)に注目し、これを毛細
胞に作用させたところ、驚くべきことに毛成長に対する
有効性があることを見いだした。ここでいうPDGFとは、
PDGFの有効断片、PDGFの修飾物、PDGFの有効断片の修飾
物およびこれらの混合物を含む。
[Means for Solving the Problems] In order to solve the above problems, the present inventor has made diligent studies and as a result, has focused on platelet-derived growth factor (PDGF), which is often contained in blood platelets, and has it act on hair cells. However, they have surprisingly found it to be effective against hair growth. PDGF here means
It includes effective fragments of PDGF, modified products of PDGF, modified products of effective fragments of PDGF, and mixtures thereof.

【0007】即ち、本発明は、血小板由来成長因子(PD
GF)を有効成分とする毛成長促進剤を提供するものであ
る。本発明に用いられるPDGFは、血小板中に存在し、線
維芽細胞、平滑筋細胞、グリア細胞などの増殖を促進す
る因子で、ヒト、マウス、ブタ等の動物の血液中の血小
板中から、例えば、ヒト血小板が含まれた血漿をイオン
交換カラムクロマトグラフィー、アフィニティーカラム
クロマトグラフィー、ゲル濾過、透析などのいずれか、
又はその組合せで処理することにより単離することがで
きる。
That is, the present invention relates to platelet-derived growth factor (PD
The present invention provides a hair growth promoter containing GF) as an active ingredient. PDGF used in the present invention is present in platelets, a factor that promotes proliferation of fibroblasts, smooth muscle cells, glial cells, etc., from human, mouse, and platelets in blood of animals such as pigs, for example, , Plasma containing human platelets is subjected to any one of ion exchange column chromatography, affinity column chromatography, gel filtration, dialysis, etc.,
Alternatively, it can be isolated by treating with a combination thereof.

【0008】より詳細には、1mMジイソプロピルフルオ
ロホスフェート(diisopropylfluorophosphate),0.05mM
フェニルメチルスルホニルフルオライド(phenylmethyls
ulfonyl fluoride), 10 mMベンザミジン(benzamidine)-
HCl,10mM EDTA, 0.03mM L−1−トシラアミド−2−
フェニル─エチルクロロメチルケトン(L-1-tosylamido
-2-phenyl-ethylchloromethyl ketone),pH6.1-6.5で10
mg/1の大豆トリプシン阻害剤(soybean trypsin inhibit
or) の存在下で一晩ヒト血小板の含まれた血漿を静置し
た後、遠心分離し、上清をゲル濾過し、PDGFの含まれる
画分を10分間煮沸する。更に遠心分離をし、上清を0.1M
NaCl, 0.01Mナトリウム燐酸緩衝液(Na-phosphate buff
er) pH7.4 で透析した後、CMーセファディクス(-Sepha
dex )の陽イオン交換クロマトグラフィーで分画する。
PDGFの含まれる画分を0.3 M NaCl, 0.01M Na-phosphate
pH7.4で透析した後ブルーセファロース(Blue-Sepharos
e)カラムで処理することにより単離することができる
〔The Journal of Biological Chemistry, 256,(17),88
96-8899,(1981)〕。また、精製されたヒトPDGFはコラボ
レーティブ、リサーチ、インコーポレーション(Collab
orative Res. Inc. )等から市販されているものを使用
してもよい。
More specifically, 1 mM diisopropylfluorophosphate, 0.05 mM
Phenylmethylsulphonyl fluoride
ulfonyl fluoride), 10 mM benzamidine-
HCl, 10 mM EDTA, 0.03 mM L-1-tosylamide-2-
Phenyl-ethyl chloromethyl ketone (L-1-tosylamido
-2-phenyl-ethylchloromethyl ketone), pH 6.1-6.5 at 10
mg / 1 soybean trypsin inhibit
or)), the plasma containing human platelets is allowed to stand overnight, then centrifuged, the supernatant is subjected to gel filtration, and the fraction containing PDGF is boiled for 10 minutes. Centrifuge further and add 0.1M of supernatant.
NaCl, 0.01M sodium phosphate buffer
er) After dialysis against pH 7.4, CM-Sephadex (-Sepha
dex) cation exchange chromatography.
The fraction containing PDGF was added to 0.3 M NaCl, 0.01 M Na-phosphate.
After dialyzing at pH 7.4, Blue-Sepharos
e) It can be isolated by treating with a column [The Journal of Biological Chemistry, 256 , (17), 88.
96-8899, (1981)]. In addition, purified human PDGF is a collaborative, research, and corporation (Collab
commercially available from orative Res. Inc.) may be used.

【0009】単離精製されたPDGFは、分子量18000
のA鎖と16000のB鎖がいくつかのS−S結合によ
って結合した、分子量34000の比較的大きな蛋白質
である。A鎖は精製の過程で切断されやすく、分子量が
11000程度まで小さくなるため、実際に得られるPD
GFの分子量は、28000乃至34000の広い範囲を
有する。分子内にシスティンを10個以上持ち、S−S
結合を形成しているが、還元処理により失活することが
知られている。また、等電点をPH9.8乃至10.2付
近に有する塩基性のペプチドであり、100℃、10分
の熱処理後に生物活性を失わない。一般にPDGFは平滑筋
細胞や線維芽細胞に対し走化性を促し、増殖促進作用も
極めて強いことから、創傷治療に作用することや動脈硬
化の一要因であることが知られている。
The isolated and purified PDGF has a molecular weight of 18,000.
It is a relatively large protein with a molecular weight of 34000, in which the A chain of A. and the B chain of 16000 are linked by some S-S bonds. Since the A chain is easily cleaved during the purification process and the molecular weight is reduced to about 11,000, the actual PD
The molecular weight of GF has a wide range of 28,000 to 34,000. Having 10 or more cystines in the molecule, SS
Although forming a bond, it is known to be inactivated by the reduction treatment. In addition, it is a basic peptide having an isoelectric point in the vicinity of pH 9.8 to 10.2 and does not lose its biological activity after heat treatment at 100 ° C for 10 minutes. Since PDGF generally promotes chemotaxis to smooth muscle cells and fibroblasts and has an extremely strong growth promoting action, it is known to act as a wound treatment and a factor in arteriosclerosis.

【0010】本発明で用いられるPDGFの断片は、例え
ば、トリプシンでPDGFを処理した後に大豆トリプシン阻
害剤を加え反応を止め、反応液をゲル濾過する事によっ
て生成したポリペプチド及び糖鎖の結合したポリペプチ
ドも含まれる。また、本発明で使われるPDGFの装飾物、
あるいはPDGFの断片の修飾物は、例えば化学合成によっ
て単糖、あるいはオリゴ糖を共有結合させたタンパク質
であるネオグリコプロテイン等を含む。
The PDGF fragment used in the present invention is, for example, a polypeptide and a sugar chain bound by treating the PDGF with trypsin, adding a soybean trypsin inhibitor to stop the reaction, and gel-filtering the reaction solution. Polypeptides are also included. Also, the PDGF ornament used in the present invention,
Alternatively, modified PDGF fragments include, for example, neoglycoprotein, which is a protein to which a monosaccharide or oligosaccharide is covalently bound by chemical synthesis, and the like.

【0011】ネオグリコプロテインの調製法の代表的な
ものとして、タンパク質のリジン残基のε−アミノ基と
N末端のα−アミノ基を糖で修飾するイミデータ方法が
挙げられる。糖による修飾の度合いは、2-イミノ-2- メ
トオキシエチル-1- チオグリコシドと蛋白質のアミノ基
の比を変化させることによって自由に変えることができ
る〔蛋白質、核酸、酵素、25(8)、707−724
(1980)〕。
A typical method for preparing neoglycoprotein is an imidator method in which the ε-amino group of the lysine residue of the protein and the N-terminal α-amino group are modified with sugar. The degree of modification with sugar can be freely changed by changing the ratio of 2-imino-2-methoxyethyl-1-thioglycoside to the amino group of protein [protein, nucleic acid, enzyme, 25 (8) , 707-724
(1980)].

【0012】本発明において、PDGFを化粧料または毛髪
料中に1ng乃至10μg/ml(またはg)、特に10ng乃至1 μ
g/ml(またはg )程度配合することにが、本発明の効果
を現わす上で望ましい。本発明の毛成長促進剤には、上
記の必須成分の他に、油分、水、界面活性剤、保湿剤、
アルコール、増粘剤、香料、酸化防止剤、キレート剤、
色素、防腐剤等外用剤として通常用いられる原料を配合
することも可能である。
In the present invention, PDGF is added to cosmetics or hair in an amount of 1 ng to 10 μg / ml (or g), particularly 10 ng to 1 μg.
It is desirable that the amount of g / ml (or g) be blended in order to exert the effect of the present invention. The hair growth promoter of the present invention includes, in addition to the above essential components, oil, water, a surfactant, a moisturizer,
Alcohol, thickener, fragrance, antioxidant, chelating agent,
It is also possible to mix raw materials usually used as external preparations such as dyes and preservatives.

【0013】また本発明は、外用剤として用いられるも
のであれば、その剤形は特に制限されないが、特に軟
膏、ローション、トニック、スプレー、懸濁液、乳剤な
どの塗布剤とするのが好ましい。
The dosage form of the present invention is not particularly limited as long as it can be used as an external preparation, but it is particularly preferable to use a coating agent such as an ointment, lotion, tonic, spray, suspension or emulsion. ..

【0014】[0014]

【発明の効果】本発明の毛成長促進剤は、毛母細胞の成
長増殖を促して毛周期上、育毛に寄与することができ
る。
The hair growth-promoting agent of the present invention can promote growth and proliferation of hair mother cells and contribute to hair growth in the hair cycle.

【0015】[0015]

【実施例】以下、実施例を挙げ、本発明を更に詳しく説
明する。
EXAMPLES The present invention will be described in more detail below with reference to examples.

【0016】[0016]

【実施例1】新生C3H系マウスの背部皮膚を、表皮と
真皮にディスパーゼを用いて酵素的に分離し、更に真皮
からコラゲナーゼを用いて毛包組織を分離した。この毛
包組織の培養液に、ヒトPDGF(Collaborative Res.
Inc.社製)を最終濃度50ng/ml及び500ng/
mlとなるように加えて培養し、3Hチミジンを用いたD
NA合成活性を測定することにより、細胞の増殖能を検
討した。下記表1に示す結果から明らかなように、強い
細胞分裂促進活性が認められた。尚、A;培養液のみ、
B;PDGF(50ng/ml)、C;PDGF(50
0ng/ml)の条件であり、表1において、Aの活性
を100%とした。
Example 1 The dorsal skin of a newborn C3H mouse was enzymatically separated from the epidermis and dermis using dispase, and hair follicle tissue was separated from the dermis using collagenase. A human PDGF (Collaborative Res.
Inc.) at a final concentration of 50 ng / ml and 500 ng /
Add 3 ml of thymidine to culture D
The proliferation ability of the cells was examined by measuring the NA synthetic activity. As is clear from the results shown in Table 1 below, strong cell division promoting activity was observed. In addition, A: culture solution only,
B: PDGF (50 ng / ml), C: PDGF (50
0 ng / ml), and in Table 1, the activity of A was defined as 100%.

【0017】[0017]

【表1】 [Table 1]

【0018】[0018]

【実施例2】1,本実施例は、毛髪成長を促進させるた
めに頭皮に塗布するのに適した養毛料の処方である。 W/V % エタノール 80.00 グリセリン 0.500 ヒトPDGF(Collaborative Res.Inc.社製:O.O1%水溶液) 0.05 色素 適量 香料 適量 精製水 適量
Example 2 1. This example is a formulation of a hair nourishing agent suitable for application to the scalp to promote hair growth. W / V% Ethanol 80.00 Glycerin 0.500 Human PDGF (Collaborative Res. Inc .: O.O 1% aqueous solution) 0.05 Dye proper amount Perfume proper amount Purified water proper amount

【0019】2,本実施例は、毛髪成長を促進させるた
めに頭皮に塗布するのに適したヘアトニックの処方であ
る。 W/V % サリチル酸 0.100 プロピレングリコール 3.00 グリチルレチン酸 0.010 1-メントール 0.100 エタノール 50.00 ヒトPDGF(Collaborative Res.Inc.社製:O.O1%水溶液) 0.05 香料 適量 精製水 適量
2. This example is a hair tonic formulation suitable for application to the scalp to promote hair growth. W / V% Salicylic acid 0.100 Propylene glycol 3.00 Glycyrrhetinic acid 0.010 1-Menthol 0.100 Ethanol 50.00 Human PDGF (Collaborative Res. Inc .: O.O1% aqueous solution) 0.05 Perfume Suitable amount Purified water Suitable amount

【0020】3,本実施例は、頭皮に刺激を与え毛髪成
長にも効果のあるエアゾルタイプの皮膜剤の処方であ
る。 W/V % エチルセルロース 8.00 グリセリン 1.00 ハッカ油 0.200 ヒトPDGF(Collaborative Res.Inc.社製:O.O1%水溶液) 0.05 エタノール 25.75 噴射剤(ジメチルエーテル) 65.00
3. The present embodiment is a formulation of an aerosol type film agent which stimulates the scalp and is effective for hair growth. W / V% Ethylcellulose 8.00 Glycerin 1.00 Mint oil 0.200 Human PDGF (Collaborative Res. Inc .: O.O1% aqueous solution) 0.05 Ethanol 25.75 Propellant (dimethyl ether) 65.00

【0021】4,本実施例は、脱毛防止の目的のために
頭皮に局所使用するローションの処方である。 W/V % イソプロパノール 1.00 ヒトPDGF(Collaborative Res.Inc.社製:O.O1%水溶液) 0.05 エタノール 4.00 香料 適量 精製水 適量
4. This example is a formulation of lotion to be used topically on the scalp for the purpose of preventing hair loss. W / V% Isopropanol 1.00 Human PDGF (Collaborative Res. Inc .: O.O 1% aqueous solution) 0.05 Ethanol 4.00 Perfume proper amount Purified water proper amount

───────────────────────────────────────────────────── フロントページの続き (72)発明者 堀田 光行 栃木県芳賀郡市貝町赤羽2606−6 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Mitsuyuki Hotta 2606-6 Akabane, Kai Town, Haga-gun, Tochigi Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 血小板由来成長因子を有効成分とする毛
成長促進剤。
1. A hair growth promoter comprising a platelet-derived growth factor as an active ingredient.
JP28533791A 1991-10-31 1991-10-31 Hair growth promoter Pending JPH05124935A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28533791A JPH05124935A (en) 1991-10-31 1991-10-31 Hair growth promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28533791A JPH05124935A (en) 1991-10-31 1991-10-31 Hair growth promoter

Publications (1)

Publication Number Publication Date
JPH05124935A true JPH05124935A (en) 1993-05-21

Family

ID=17690249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28533791A Pending JPH05124935A (en) 1991-10-31 1991-10-31 Hair growth promoter

Country Status (1)

Country Link
JP (1) JPH05124935A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102441008A (en) * 2010-10-09 2012-05-09 中央医疗器材股份有限公司 Hair growth stimulator containing platelet powder
US20130067604A1 (en) * 2010-02-24 2013-03-14 Sadatoshi Sakuma Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth
CN105079789A (en) * 2014-05-21 2015-11-25 宋铭瑄 Use of platelet-derived growth factor for whitening and darkening hair
JP2016079177A (en) * 2014-10-14 2016-05-16 訊聯生物科技股▲分▼有限公司 Composition which promotes growth of dermal papilla cell, method for manufacturing the same, and medicinal drug containing the composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130067604A1 (en) * 2010-02-24 2013-03-14 Sadatoshi Sakuma Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth
CN102441008A (en) * 2010-10-09 2012-05-09 中央医疗器材股份有限公司 Hair growth stimulator containing platelet powder
CN105079789A (en) * 2014-05-21 2015-11-25 宋铭瑄 Use of platelet-derived growth factor for whitening and darkening hair
JP2016079177A (en) * 2014-10-14 2016-05-16 訊聯生物科技股▲分▼有限公司 Composition which promotes growth of dermal papilla cell, method for manufacturing the same, and medicinal drug containing the composition

Similar Documents

Publication Publication Date Title
US4935231A (en) Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
JP2594587B2 (en) Cosmetic composition
JPS6069012A (en) Skin care composition
US4738841A (en) Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
CN111315387A (en) Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
KR20150066811A (en) Cosmetics compositions for hair growth promoter
JPH02152928A (en) Antistimulant and desensitizing composition and its usage
JP3597210B2 (en) Hair restoration
JPH09183718A (en) Composition suitable for external application
AU673742B2 (en) Composition for reducing hair loss or stimulating hair growth
JPH05124935A (en) Hair growth promoter
KR100348155B1 (en) The hair-growing agent composition which is contained the extract from natural phellinus linteus and preparation method using the same
JP2953529B2 (en) New cosmetics
HU193289B (en) Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4919924A (en) Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
JPH02108615A (en) Alkyl polyglycoside andpyrimidine derivative base composition
JP2001288048A (en) Composition for scalp and hair
JPH0912432A (en) Hair tonic
JPH01242516A (en) Hair tonic, hair shampoo and hair growing promoter
JPH1095704A (en) Composition suitable for external use
JPH0338511A (en) External preparation
JPH05170625A (en) Hair tonic
US4761278A (en) Ladies aftershave preparation and method for its manufacture
RU2195255C2 (en) Cosmetic and dermatological remedy and method of skin and/or keratin materials treatment
JPH11512091A (en) Composition containing peptide cell growth promoter